|
Mutation Information
|
Mutation Site
|
L100I |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Relevant Drug
|
NNRTIs;etravirine (ETR);rilpivirine (RPV);doravirine (DOR) |
Literature Information
|
PubMed PMID
|
32266208
|
|
Published Year
|
2020 |
|
Journal
|
Frontiers in chemistry |
|
Title
|
In silico Design of Novel HIV-1 NNRTIs Based on Combined Modeling Studies of Dihydrofuro[3,4-d]pyrimidines. |
|
Author
|
Chen Y,Tian Y,Gao Y,Wu F,Luo X,Ju X,Liu G |
|
Evidence
|
However, single mutations such as K103N, Y181C, V106A, and L100I in the binding site of the HIV-1 RT might result in decreased inhibitory potencies of NNRTIs, and a double mutation (K103N+Y181C) was more frequently discovered in the process of treating with NNRTIs (Das et al.,).
|
|
|
HIV Mutation Detail Information